{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T02:10:56Z","timestamp":1778033456646,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.urolonc.2022.11.005","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T07:31:40Z","timestamp":1669620700000},"page":"255.e15-255.e21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Disparities in the prevalence and management of high-risk non-muscle invasive bladder cancer"],"prefix":"10.1016","volume":"41","author":[{"given":"Angela","family":"Estevez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumedh","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Fleishman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruslan","family":"Korets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquim","family":"Bellmunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aria F.","family":"Olumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi","family":"Rayala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Gershman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.urolonc.2022.11.005_bib0001","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J Urol"},{"issue":"10","key":"10.1016\/j.urolonc.2022.11.005_bib0002","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.urolonc.2020.06.013","article-title":"Low compliance to guidelines in nonmuscle-invasive bladder carcinoma: a systematic review","volume":"38","author":"Mori","year":"2020","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2022.11.005_bib0003","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.urolonc.2011.08.011","article-title":"Disparities in bladder cancer","volume":"30","author":"Jacobs","year":"2012","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2022.11.005_bib0004","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.urology.2019.09.058","article-title":"Health care disparities in urologic oncology: a systematic review","volume":"136","author":"Das","year":"2020","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.urolonc.2022.11.005_bib0005","doi-asserted-by":"crossref","first-page":"e995","DOI":"10.1016\/j.clgc.2019.05.008","article-title":"Racial and socioeconomic disparities in bladder cancer survival: analysis of the California cancer registry","volume":"17","author":"Sung","year":"2019","journal-title":"Clin Genitourin Cancer"},{"issue":"3","key":"10.1016\/j.urolonc.2022.11.005_bib0006","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/cncr.32562","article-title":"The impact of underinsurance on bladder cancer diagnosis, survival, and care delivery for individuals under the age of 65 years","volume":"126","author":"Fletcher","year":"2020","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.urolonc.2022.11.005_bib0007","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/cncr.31926","article-title":"Impact of tumor, treatment, and access on outcomes in bladder cancer: Can equal access overcome race-based differences in survival?","volume":"125","author":"Cole","year":"2019","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.urolonc.2022.11.005_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2017.12.015","article-title":"Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: An update from the National Cancer Data Base (2004-2013)","volume":"36","author":"Weiner","year":"2018","journal-title":"Urol Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2022.11.005_bib0009","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.juro.2008.04.016","article-title":"Predictors of intravesical therapy for nonmuscle invasive bladder cancer: results from the surveillance, epidemiology and end results program 2003 patterns of care project","volume":"180","author":"Huang","year":"2008","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2022.11.005_bib0010","doi-asserted-by":"crossref","first-page":"e461","DOI":"10.1016\/j.clgc.2019.01.007","article-title":"Determinants of guideline-based treatment in patients with cT1 bladder cancer","volume":"17","author":"Balakrishnan","year":"2019","journal-title":"Clin Genitourin Cancer"},{"issue":"23","key":"10.1016\/j.urolonc.2022.11.005_bib0011","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.1002\/cncr.26198","article-title":"Compliance with guidelines for patients with bladder cancer: variation in the delivery of care","volume":"117","author":"Chamie","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2022.11.005_bib0012","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.urology.2019.03.035","article-title":"Care quality and variability in the use of intravesical therapy for initial treatment of nonmuscle invasive bladder cancer within a large, diverse integrated delivery system","volume":"131","author":"Danforth","year":"2019","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.urolonc.2022.11.005_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2019.01.007","article-title":"Disparities in the diagnostic evaluation of microhematuriaand implications for the detection of urologic malignancy","volume":"37","author":"Matulewicz","year":"2019","journal-title":"Urol Oncol"},{"issue":"13","key":"10.1016\/j.urolonc.2022.11.005_bib0014","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/cncr.30029","article-title":"Sex disparities in use of chemotherapy and survival in patients with advanced bladder cancer","volume":"122","author":"Rose","year":"2016","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.urolonc.2022.11.005_bib0015","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3961\/jpmph.18.092","article-title":"Demographic and Survivorship Disparities in non-muscle-invasive bladder cancer in the United States","volume":"51","author":"Seo","year":"2018","journal-title":"J Prev Med Public Health Yebang Uihakhoe Chi"},{"issue":"1","key":"10.1016\/j.urolonc.2022.11.005_bib0016","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/cncr.24701","article-title":"Racial differences in treatment and outcomes among patients with early stage bladder cancer","volume":"116","author":"Hollenbeck","year":"2010","journal-title":"Cancer"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143922004446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143922004446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:26:39Z","timestamp":1761042399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143922004446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1078143922004446"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2022.11.005","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disparities in the prevalence and management of high-risk non-muscle invasive bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2022.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}